cervical spinal cord injury
-
Spine
StemCells, Inc. Announces Commencement of the Second Cohort of the Pathway(TM) Study in Cervical Spinal Cord Injury
StemCells, Inc. STEM, +0.00% a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system diseases…
Read More » -
Spine
StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury
NEWARK, Calif., Apr 16, 2015 (GLOBE NEWSWIRE via COMTEX) — StemCells, Inc. STEM, +1.59% a leading stem cell company developing…
Read More »